Avant Diagnostics Announces Restructuring and Private Placement
WASHINGTON, May 30, 2018 /PRNewswire/ — Avant Diagnostics, Inc. (“Avant”) (OTC: AVDX), an oncology-focused healthcare data-generating solutions company commercializing the proprietary Theralink® phospho-protein biomarker platform across multiple cancers, today announced…